American Heart Journal
Volume 155, Issue 1 , Pages 62-68, January 2008

Kidney dysfunction and fatal cardiovascular disease—an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study

  • Rajat Deo, MD

      Affiliations

    • Division of Cardiology, Johns Hopkins Hospital, Baltimore, MD
  • ,
  • Christina L. Wassel Fyr, MS

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA
    • Department of Epidemiology and Biostatistics, University of California, San Francisco, CA
  • ,
  • Linda F. Fried, MD, MPH

      Affiliations

    • The Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • Renal Section, VA Pittsburgh Healthcare System, Pittsburgh, PA
  • ,
  • Anne B. Newman, MD, MPH

      Affiliations

    • Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA
    • Division of Geriatric Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • ,
  • Tamara B. Harris, MD, MS

      Affiliations

    • Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging, Bethesda, MD
  • ,
  • Sara Angleman

      Affiliations

    • Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging, Bethesda, MD
  • ,
  • Christie Green, MD

      Affiliations

    • Division of Nephrology, Department of Medicine, University of Tennessee, Memphis, TN
  • ,
  • Stephen B. Kritchevsky, PhD

      Affiliations

    • J. Paul Sticht Center on Aging and Rehabilitation, Wake Forest Bowman Gray School of Medicine, Winston-Salem, NC
  • ,
  • Glenn M. Chertow, MD, MPH

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA
    • Department of Epidemiology and Biostatistics, University of California, San Francisco, CA
  • ,
  • Steven R. Cummings, MD

      Affiliations

    • California Pacific Medical Center Research Institute, San Francisco, CA
  • ,
  • Michael G. Shlipak, MD, MPH

      Affiliations

    • General Internal Medicine Section, Veterans Affairs Medical Center, San Francisco, CA
    • Corresponding Author InformationReprint requests: Michael G. Shlipak, MD, MPH, University of California, San Francisco, General Internal Medicine Section, VA Medical Center (111A1), 4150 Clement Street, San Francisco, CA 94121.
  • ,
  • for the Health ABC study

Received 16 March 2007; accepted 12 August 2007. published online 08 October 2007.

Background

Impaired kidney function has been associated with increased risk for death, myocardial infarction, stroke, and heart failure in high-risk populations. We evaluated whether impaired kidney function predicted risk of fatal cardiovascular disease independent of prevalent and incident cardiovascular events.

Methods

The Health, Aging, and Body Composition study is a cohort of well-functioning, elderly participants aged 70 to 79 years at entry. We measured serum cystatin C and creatinine from baseline plasma samples of 3044 participants and followed them over 6 years, examining the associations among kidney function, cardiovascular death, and incident cardiovascular events. Cystatin C was categorized as low (<0.84 mg/L), medium (0.84-1.18 mg/L), or high (≥1.19 mg/L); serum creatinine (cutoff value of ≥1.3 in women and ≥1.5 in men) and estimated glomerular filtration rate (eGFR; greater and less than 60 mL/min per 1.73 m2) were dichotomized.

Results

During follow-up, 242 cardiovascular deaths occurred, of which 69 were in participants without prior cardiovascular events; 294 incident cardiovascular events occurred including 135 myocardial infarctions and 163 strokes. Higher cystatin C concentrations were significantly associated with cardiovascular death (adjusted hazard ratio [HR] 1.70, 95% confidence interval [CI] 1.05-2.76 for the medium cystatin C group; and HR 2.24, 95% CI 1.30-3.86 for the high cystatin C group, relative to the low cystatin C group). The point estimate was of greater magnitude in the analysis that excluded prevalent cardiovascular disease (adjusted HR 2.68, 95% CI 0.94-7.70 for the medium cystatin C group; and HR 4.91, 95% CI, 1.55-15.54 for the high cystatin C group). Elevated creatinine levels (adjusted HR 1.54, 95% CI 1.02-2.33, and HR 2.28, 95% CI 1.10-4.73 among participants without a history of cardiovascular disease) were also associated with cardiovascular death. No significant association was found between low eGFR and cardiovascular death. In addition, cystatin C, low eGFR, or elevated creatinine levels were not associated with other cardiovascular events.

Conclusion

Impaired kidney function is a strong predictor of cardiovascular death, particularly among participants without prior history of cardiovascular disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Health ABC was supported through the National Institute on Aging contracts N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106. This research was supported in part by the Intramural Research program of the NIH, National Institute on Aging.

PII: S0002-8703(07)00687-4

doi:10.1016/j.ahj.2007.08.012

American Heart Journal
Volume 155, Issue 1 , Pages 62-68, January 2008